Innovative Biotherapies
Innovative Biotherapies Inc. (IBT) is a for-profit company founded in 2003 by Dr. H. David Humes, a Professor of Medicine at the University of Michigan. The company is dedicated to facilitating the commercialization of technology developed in Dr. Humes' academic laboratory, focusing on bioartificial organ-based devices utilizing adult progenitor cells, biomaterials, and MEMS technology.
IBT's research and development initiatives are primarily supported by various federal grants and contracts, showcasing the company's commitment to advancing innovative biotherapies. Through these efforts, IBT aims to enhance the therapeutic landscape with cutting-edge solutions in regenerative medicine.
Generated from the website
Also at this address
Partial Data by Foursquare.
